Automate Your Wheel Strategy on MDT
With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDT
- Rev/Share 26.1538
- Book/Share 37.6324
- PB 2.2891
- Debt/Equity 0.5938
- CurrentRatio 1.8491
- ROIC 0.0608
- MktCap 109952154200.0
- FreeCF/Share 4.0435
- PFCF 21.2058
- PE 23.5753
- Debt/Assets 0.311
- DivYield 0.0327
- ROE 0.0962
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | MDT | Leerink Partners | -- | Outperform | -- | $110 | June 16, 2025 |
| Upgrade | MDT | Citigroup | Neutral | Buy | $92 | $107 | March 4, 2025 |
| Upgrade | MDT | RBC Capital Mkts | Sector Perform | Outperform | $98 | $105 | Oct. 10, 2024 |
| Reiterated | MDT | Oppenheimer | -- | Perform | $92 | $94 | Aug. 21, 2024 |
News
Why Is Medtronic (MDT) Up 6% Since Last Earnings Report?
Published: June 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Read More
6 Upcoming Dividend Increases
Published: June 19, 2025 by: Seeking Alpha
Sentiment: Positive
I focus on companies with consistent dividend growth, using a blend of the U.S. Dividend Champions list and NASDAQ data for my selections. This week's highlighted group averages a 5.9% dividend increase and a 19.5-year streak, but none outperformed the SCHD ETF over the past decade. While SCHD remains my benchmark for dividend growth and total return, I look for individual stocks that can deliver significant alpha over it.
Read More
Medtronic Announces Intent To Spin Diabetes Business
Published: June 09, 2025 by: Forbes
Sentiment: Positive
Deal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business into a standalone entity (New Diabetes Company). This strategic move is designed to streamline Medtronic's portfolio, sharpen its focus on high-margin growth areas, and unlock shareholder value.
Read More
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Bernstein's 41st Strategic Decisions Conference Call May 29, 2025 11:00 AM ET Company Participants Geoff Martha - Chairman and Chief Executive Officer Thierry Pieton - Executive Vice President and Chief Financial Officer Conference Call Participants Lee Hambright - Bernstein Lee Hambright All right. Very good.
Read More
ISRG vs. MDT: Which Robotic Surgery Stock Is a Smarter Buy Now?
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
Intuitive Surgical or Medtronic -- who leads the future of robotic surgery? Here's a comparative analysis to help you make a smart choice for 2025.
Read More
No Rolex For Me - I'm Buying Dividends That Pay For Life
Published: May 26, 2025 by: Seeking Alpha
Sentiment: Positive
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable long-term returns. A $10K McDonald's investment in 2004 would've yielded over $22K in dividends alone. History shows that strong-yielding dividend stocks, especially those in the second quintile, have consistently outperformed the market with lower risk.
Read More
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Published: May 25, 2025 by: Seeking Alpha
Sentiment: Positive
Upgrading Medtronic to 'Strong Buy' with a $104 fair value, driven by the diabetes business spin-off catalyst. Divesting diabetes enables Medtronic to focus on core cardiac and surgical markets, improving operating margins and capital allocation. Recent results show robust cardiovascular growth and strong shareholder returns, with continued buybacks expected post-spin-off.
Read More
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
Published: May 22, 2025 by: Fox Business
Sentiment: Positive
Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets
Read More
Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
Published: May 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Q4 2025 Earnings Conference Call May 21, 2025 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head of IR Geoff Martha - Chairman and CEO Que Dallara - EVP & President, Diabetes Thierry Pieton - CFO Sean Salmon - EVP and President of Cardiovascular Portfolio Brett Wall - EVP and President of Neuroscience Portfolio Conference Call Participants Travis Steed - Bank of America Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Vijay Kumar - Evercore Joanne Weunsch - Citi Matt Taylor - Jefferies Matt Miksic - Barclays Danielle Antalffy - UBS Shagun Singh …
Read More
Compared to Estimates, Medtronic (MDT) Q4 Earnings: A Look at Key Metrics
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Medtronic to split off its fast-growing diabetes business to unlock its value
Published: May 21, 2025 by: Market Watch
Sentiment: Positive
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
Read More
Medtronic (MDT) Q4 Earnings and Revenues Beat Estimates
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.46 per share a year ago.
Read More
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
Published: May 21, 2025 by: PRNewsWire
Sentiment: Neutral
Building momentum in key franchises including Pulsed Field Ablation, TAVR, Cardiac Rhythm Management, Diabetes, Spine, and Neuromodulation GALWAY, Ireland , May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2025 (FY25), which ended April 25, 2025. Q4 Key Highlights Q4 revenue of $8.9 billion increased 3.9% as reported and 5.4% organic Q4 GAAP diluted EPS of $0.82 increased 67%; non-GAAP diluted EPS of $1.62 increased 11% Q4 operating margin increased 380 basis points; Q4 non-GAAP operating margin increased 90 basis points Q4 …
Read More
Medtronic announces intent to separate Diabetes business
Published: May 21, 2025 by: PRNewsWire
Sentiment: Neutral
Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies Leading, scaled, direct-to-consumer Diabetes business poised to become standalone company; only company with a complete ecosystem to address intensive insulin management GALWAY, Ireland , May 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This strategic decision for both Medtronic and New Diabetes Company will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets.
Read More
Medtronic to separate diabetes business, WSJ reports
Published: May 21, 2025 by: Reuters
Sentiment: Neutral
Medical device maker Medtronic plans to separate its diabetes business into a stand-alone company, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Read More
Medtronic to Separate Diabetes Business
Published: May 21, 2025 by: WSJ
Sentiment: Neutral
The medical device maker has been working to turn around the division over the last few years.
Read More
Will Medtronic's Earnings Move The Stock?
Published: May 19, 2025 by: Forbes
Sentiment: Neutral
Medtronic (NYSE:MDT) is scheduled to announce its earnings on Wednesday, May 21, 2025. Over the last five years, Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.
Read More
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Published: May 18, 2025 by: The Motley Fool
Sentiment: Positive
Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal.
Read More
Trump tariff 'tornado' still hunting markets: Former Medtronic CEO
Published: May 16, 2025 by: Yahoo Finance
Sentiment: Negative
You can catch Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. There has been one common theme from Corporate America throughout the last two months as the Trump administration's trade war has taken hold: shot-calling CEOs have been frozen in their normally hard-charging tracks.
Read More
What Analyst Projections for Key Metrics Reveal About Medtronic (MDT) Q4 Earnings
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
Should You Continue to Hold Medtronic Stock in Your Portfolio Now?
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.
Read More
Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Positive
Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year, but now faces a pivotal earnings event on the 21st of May. Cardiovascular portfolio strength, especially from Pulse Field Ablation products, and a convalescing medical surgical outlook, underpin our optimism, while gross margin and SG&A progress is likely to be seen. While the expected dividend hike may not be meaningful (potentially at less than 2%), that's not because MDT doesn't have the capabilities to be more generous with strong FCF coverage.
Read More
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21, 2025. A news release will be issued at approximately 5:45 a.m.
Read More
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
Star Jones, award winning television personality & women's heart health advocate, helps kick off heart health conversations this Mother's Day with the Medtronic 'Letter to My Mother' campaign GALWAY, Ireland , May 7, 2025 /PRNewswire/ -- A new Medtronic-sponsored survey of women ages 30-50 reveals a significant gap in awareness and discussion around heart health among women and their mother-figures. Despite cardiovascular disease being the #1 killer of women in the U.S., many women are still unaware of the risk and the importance of heart health.
Read More
Smart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RF
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized medicine. North America leads with USD 455.5 million in 2024. The market benefits from tech advancements, an aging population, and robust healthcare infrastructure, paving the way for continuous growth. Key growth drivers include the rise of gastrointestinal disorders and demand for non-invasive diagnostics. Smart pills, equipped with sensors and AI, facilitate real-time monitoring and personalized medicine. North America leads with USD 455.5 million in 2024. The market benefits from tech advancements, an aging population, …
Read More
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years
Published: April 26, 2025 by: The Motley Fool
Sentiment: Positive
Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.
Read More
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
Published: April 26, 2025 by: PRNewsWire
Sentiment: Neutral
Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration GALWAY, Ireland and LAS VEGAS , April 26, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption (IDE) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. The prospective, multi-center, single-arm IDE study included 137 patients who underwent …
Read More
Prediction: Buying Medtronic Today Will Set You Up for Life
Published: March 28, 2025 by: The Motley Fool
Sentiment: Positive
Healthcare can be a complex sector, and it is one that I long ago decided to outsource to the industry professionals who run closed-end fund Blackrock Health Sciences Trust. But I couldn't resist dipping my toe into the sector when I saw the historically high yield on offer from Medtronic (MDT 0.88%), one of the largest and most diversified medical device makers.
Read More
2 Recession-Proof Dividend Stocks to Buy and Hold
Published: March 27, 2025 by: The Motley Fool
Sentiment: Neutral
Fears of a looming recession seem to be rising, partly fueled by President Donald Trump's macroeconomic policies. While it's impossible to predict whether an economic downturn is indeed coming, it's not a bad idea for investors to purchase shares of companies that are likely to perform relatively well in case it does happen.
Read More
Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension?
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medtronic's Hypertension business is on the brink of a major expansion, driven by its Simplicity blood pressure procedure.
Read More
About Medtronic plc (MDT)
- IPO Date 1973-05-02
- Website https://www.medtronic.com
- Industry Medical - Devices
- CEO Mr. Geoffrey Straub Martha
- Employees 95000